Wallstreet Hotties of the Day: AngloGold Ashanti Ltd. (NYSE:AU), MiMedx Group, Inc. (NASDAQ:MDXG)

AngloGold Ashanti Ltd. (NYSE:AU)

The shares of AngloGold Ashanti Ltd. (NYSE:AU) started off the last trading session with the price of $9 while closing the day with the price of $9.04. The shares of AngloGold Ashanti Ltd. (NYSE:AU) Rise 0.78% with the Gain of 0.04 points.

The shares of AngloGold Ashanti Ltd. (NYSE:AU) traded with the day volume of 2.49 Million shares whereas its average trading volume is 3.09 Million.

While analyzing the past performance of the stock we can see that the shares of AngloGold Ashanti Ltd. (NYSE:AU) Loss -6.13% in the last week while Falling -15.83% in the last month. Past quarter performance shows the red light with -1.31%. The semi-annual and annual performance shows -9.05% and -16.37% respectively.

Some critical values of the shares of AngloGold Ashanti Ltd. (NYSE:AU) to be discussed here are: the beta which shows the value at -0.92 while Average True Range of AngloGold Ashanti Ltd. (NYSE:AU) demonstrate the value at 0.31. The weekly and monthly volatility of the shares of AngloGold Ashanti Ltd. (NYSE:AU) are indicated at 2.56% and 2.70%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 33.45.

While studying the financial position of the shares of AngloGold Ashanti Ltd. (NYSE:AU), we can see that the Market capitalization of the company is at 3.81 Billion. The shares outstanding for the company is 421.15 Million and the shares float stands at 399.48 Million. The income of the company stand at -191000000 while the sales stand at 4.36 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.46, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 0.87, the Return on Asset ROA stood at 0.009 and the Return on Equity ROE depicted at 0.024 while Return on Investment ROI is at 0.063.


MiMedx Group, Inc. (NASDAQ:MDXG)

MiMedx Group, Inc. (NASDAQ:MDXG) started its previous trading session at $7.35 and closed at $7.22 showing a Fell of -1.9 Percent.

The Company traded with an average Volume of 3.41 Million whereas, its Day Volume stood at 2.49 Million.

Looking at the performance of the stock, MiMedx Group, Inc. (NASDAQ:MDXG) Loss -4.75% in the last week in its shares price and -53.21% in the last month. Quarterly performance shows a red of -40.53 Percent while Semi-Annual and Annual performances shows a -46.76 and -18.42 percent respectively.

Beta for MiMedx Group, Inc. (NASDAQ:MDXG) stands at 1.63 while the ATR (average true range) is at 0.84. The Stock’s Weekly and Monthly Volatility is 7.01% and 10.10% respectively showing a RSI value of 31.55.

While studying the financial position of the shares of MiMedx Group, Inc. (NASDAQ:MDXG), we can see that the Market capitalization of the company is at 775.57 Million. The shares outstanding for the company is 107.42 Million and the shares float stands at 102.71 Million.

The Company generated an income of 35.3 Million and the sales of 303.5 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.3 a share. P/E (price to earnings) and P/S (price to sales) values are 23.75 and 2.56 respectively.

The Return on Assets stands at 0.186, ROE shows a value of 0.256 and ROI for MiMedx Group, Inc. (NASDAQ:MDXG) is 0.093 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment